Fascia manipulation for the treatment of muscle pain

Evaluation of Fascial Manipulation method on effectiveness in treatment of myofascial pain: a randomised controlled trial of various treatment protocols and their influence on pain levels, the reactivity of soft tissues, change in USG imaging (including elastography), EMG, range of motion, function, and Neurac's tests

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13533739

Enrollment

100

Registered

2020-01-15

Start date

2020-01-15

Completion date

Unknown

Last updated

2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain Musculoskeletal Diseases Myofascial pain

Interventions

Patients will be randomly allocated (using a computer program) to one of three groups, where each group will have a different therapy protocol and there will be a control group with no therapy as well

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 18-40 2. Presence of musculoskeletal pain for at least 1 week or healthy with no pain (for control group)

Exclusion criteria

Exclusion criteria: 1. Coexistence of a chronic or systemic disease 2. Pregnancy 3. Taking steroids, anti-inflammatory drugs or drugs that change blood coagulability 4. Acute injuries 5. Acute surgical interventions 6. The use of other therapeutic forms 7. Serious neurological disorders

Design outcomes

Primary

Measure	Time frame
Measured before and after first therapy, after third therapy and after 30 days (follow-up): 1. Pain levels - VAS scale 2. Reactivity of soft tissues - MyotonPro device	—

Secondary

Measure	Time frame
Measured before and after first therapy, after third therapy and after 30 days (follow-up): 1. Change in USG imaging (including elastography) (USG Device) 2. EMG (EMG device) 3. Range of motion (digital inclinometer) 4. Function (FMS) 5. Proprioception (kinesthesia tests) 6. Neuromuscular activation test using Neurac test protocol.	—

Countries

Poland

Contacts

Public ContactMateusz Pawlukiewicz

m.pawlukiewicz@awf.katowice.pl+48 508852486

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026